GENMARK DIAGNOSTICS INC - COM (GNMK)

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
47,607,896
Share change
+3,933,145
Total reported value
$561,764,549
Put/Call ratio
0%
Price per share
$11.80
Number of holders
91
Value change
+$49,229,956
Number of buys
51
Number of sells
31

Institutional Holders of GENMARK DIAGNOSTICS INC - COM (GNMK) as of Q3 2016

As of 30 Sep 2016, GENMARK DIAGNOSTICS INC - COM (GNMK) was held by 91 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,607,896 shares. The largest 10 holders included FMR LLC, PUTNAM INVESTMENTS LLC, PRICE T ROWE ASSOCIATES INC /MD/, CADIAN CAPITAL MANAGEMENT, LP, JPMORGAN CHASE & CO, JENNISON ASSOCIATES LLC, MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., HighTower Advisors, LLC, and Artisan Partners Limited Partnership. This page lists 91 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.